You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

G533C

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjögren's Syndrome Trial in Worldwide (CFZ533 (iscalimab), CFZ533 Placebo)

Recruiting
  • Sjögren's Syndrome
  • CFZ533 (iscalimab)
  • CFZ533 Placebo
  • Duluth, Georgia
  • +54 more
Oct 14, 2022

Myasthenia Gravis, Generalized Trial in Worldwide (Placebo, CFZ533)

Completed
Has Results
  • Myasthenia Gravis, Generalized
  • Montreal, Quebec, Canada
  • +14 more
Dec 9, 2020

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Elobixibat 10mg + cholestyramine powder 9g

Completed
  • Nonalcoholic Fatty Liver
  • Nonalcoholic Steatohepatitis
  • Elobixibat 10mg + cholestyramine powder 9g (cholestyramine 4g)
  • +3 more
  • Yokohama, Kanagawa, Japan
    Yokohama City University
Nov 15, 2021

Liver Transplant Rejection Trial in Worldwide (CFZ533, Tacrolimus - MMF - corticosteroids)

Active, not recruiting
  • Liver Transplant Rejection
  • CFZ533
  • Tacrolimus - MMF - corticosteroids
  • Los Angeles, California
  • +28 more
Jan 17, 2023

Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

Enrolling by invitation
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Olga
Jun 19, 2023

Lupus Nephritis Trial in Worldwide (CFZ533, Placebo)

Active, not recruiting
  • Lupus Nephritis
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +20 more
Aug 23, 2022

Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • (no location specified)
Aug 11, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)

Active, not recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +31 more
Sep 19, 2022

KRAS P.G12C, Pancreatic Cancer Trial in Beijing (JAB-21822)

Not yet recruiting
  • KRAS P.G12C
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +1 more
Aug 18, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Post Operative Atrial Fibrillation Trial in Giza (Vitamin C 500 MG Oral Capsule(High dose 2g daily), Vitamin C 500 MG Oral

Active, not recruiting
  • Post Operative Atrial Fibrillation
  • Vitamin C 500 MG Oral Capsule(High dose 2g daily)
  • +2 more
  • Giza, Egypt
    El Sheik Zayed Specialized Hospital
Oct 7, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

Not yet recruiting
  • C3G
  • +11 more
  • (no location specified)
Apr 13, 2023

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2022

C3 Glomerulopathy Trial (NM8074)

Not yet recruiting
  • C3 Glomerulopathy
  • (no location specified)
Jan 12, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

Recruiting
  • KRAS P.G12C
  • Non Small Cell Lung Cancer
  • Sotorasib 120Mg Tab
  • Lyon, France
  • +3 more
Dec 16, 2022

Dental Caries Trial in Kalispell, Bedford, Irving (27.2 mg C16G2 Varnish, 13.6 mg C16G2 Varnish, 54.4 mg C16G2 Varnish)

Completed
Has Results
  • Dental Caries
  • C16G2 Varnish
  • Placebo Varnish
  • Kalispell, Montana
  • +2 more
Dec 8, 2022

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023

The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

Recruiting
  • Beta-Thalassemia
  • ARMS PCR
  • Assiut, Egypt
    Faculty of Medicine Assiut University
Jan 30, 2023

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023